UG Medical School Refutes Social Media Claims of Cassava-Based Diabetes Cure

The University of Ghana Medical School (UGMS) has strongly refuted claims circulating on social media that its researchers have developed a cassava-based compound, allegedly named “cassavarin,” which is said to reverse Type 2 diabetes.

In an official statement, the Medical School described the publication as entirely false and misleading, stressing that no such research has been conducted under its auspices. UGMS clarified that it has not isolated any compound known as “cassavarin,” nor has it carried out laboratory studies or clinical trials related to the treatment or reversal of Type 2 diabetes using cassava or any cassava-derived substance.

The statement further dismissed as fabricated claims suggesting that the alleged compound had received regulatory approval, been involved in pharmaceutical lawsuits, or entered into licensing agreements. According to UGMS, none of these assertions have any basis in fact and do not reflect the School’s research activities or processes.

UGMS emphasised that it operates under strict scientific, ethical, and regulatory standards, noting that all legitimate research conducted by the institution undergoes rigorous peer review, ethical clearance, and regulatory oversight before findings are communicated to the public. As such, any genuine breakthrough of the magnitude described would only be announced through official University of Ghana channels and recognised scientific platforms.

The Medical School cautioned the public against relying on unverified information shared on social media, particularly on matters related to health and medical treatment, as such misinformation can pose serious risks to public health. It urged the public, patients, and healthcare practitioners to seek accurate and reliable information from approved sources.

UGMS also stated that it has formally dissociated itself from the misinformation and is taking appropriate steps to address the situation, including investigating the source of the false claims and exploring possible measures to prevent further dissemination.

The statement, signed by the Dean of the University of Ghana Medical School, reaffirmed the institution’s commitment to scientific integrity, ethical research practices, and responsible public communication, while encouraging the public to remain vigilant and discerning in the consumption of health-related information.